SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Needham Maintains Buy on Cidara Therapeutics, Lowers Price Target to $6

Needham analyst Alan Carr maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and lowers the price target from $10 to $6.

Benzinga · 03/05/2020 12:44

Needham analyst Alan Carr maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and lowers the price target from $10 to $6.